The Indonesia Impact Fund has invested US$500,000 in Jakarta-based biotechnology start-up Greenhope, aimed at advancing sustainability through biodegradable bioplastics.

Information on the Target

Greenhope is a Jakarta-based biotechnology start-up specializing in the production of biodegradable bioplastic products derived from cassava. The company is committed to sustainability and aims to contribute to environmentally friendly solutions in the bioplastics sector.

As part of its mission, Greenhope seeks to innovate within the biotechnology industry, addressing the growing demand for sustainable materials while alleviating the environmental impact associated with traditional plastics.

Industry Overview in Indonesia

Indonesia's biotechnology sector has been rapidly evolving, driven by increasing awareness of environmental issues and sustainability. The industry

View Source

Similar Deals

Tenity PaperlessHospital

2025

Other VC Healthcare Facilities & Services (NEC) Indonesia
AngelCentral Alodokter

2024

Other VC Telemedicine Services Indonesia
Industrifonden Zymego

2026

Other VC Healthcare Facilities & Services (NEC) Sweden
AREV I NexInLife

2026

Other VC Medical Devices & Implants France
Unknown Aeon

2025

Other VC Medical & Diagnostic Laboratories Other
GOCA3 Technologie de mesure de fluidité membranaire

2025

Other VC Bio Diagnostics & Testing Other

Indonesia Impact Fund

invested in

Greenhope

in

in a Other VC deal

Disclosed details

Transaction Size: $1M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert